Loading…

MilliporeSigma is investing $65 million to expand its high-potent active pharmaceutical ingredient and antibody-drug conjugate manufacturing capabilities at its facility near Madison, Wisconsin, adding approximately 50 jobs.
“MilliporeSigma today announced a $65 million expansion of its HPAPI and ADC manufacturing capabilities and capacity at its facility near Madison, Wisconsin.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.